Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
PAVmed Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-36.8% vs price
Base Case (Median)
12.9% vs price
Bull Case (75th pct.)
62.5% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| Graham Number | $11.37 | 112.1% | Medium (40%) |
| EV/EBITDA | $0.73 | -86.4% | Medium (20%) |
Based on 2 out of 8 methods, PAVM appears fairly valued at the current price of $5.36. The base case fair value of $6.05 implies 12.9% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.